Susanne Gatz

Medicine & Life Sciences

1. Rhabdomyosarcoma 100%
2. Pediatrics 67%
3. Sarcoma 66%
4. Child 42%
5. Desmoplastic Small Round Cell Tumor 37%
6. Neoplasms 31%
7. proteasome maturation protein 29%
8. Clinical Trials 26%
9. Young Adult 25%
10. Re-Irradiation 23%
11. Synovial Sarcoma 20%
12. Mutation 18%
13. Therapeutics 18%
14. Severe Combined Immunodeficiency 17%
15. Ifosfamide 17%
16. Temozolomide 17%
17. Investigational Therapies 17%
18. Ewing's Sarcoma 17%
19. Irinotecan 16%
20. Survival 15%
21. Precision Medicine 15%
22. Vincristine 15%
23. Drug Therapy 14%
24. Maxilla 14%
25. Group Psychotherapy 14%
26. Recurrence 13%
27. Standard of Care 13%
28. Positron-Emission Tomography 13%
29. DNA Repair 12%
30. Doxorubicin 12%
31. DNA Damage 12%
32. Nuclear Proteins 10%
33. Cytidine Deaminase 10%
34. Systematic Reviews 10%
35. Circulating Tumor DNA 10%
36. Odontogenic Tumors 9%
37. Pharmaceutical Preparations 9%
38. RAG-1 Genes 7%
39. Genes 7%
40. Radiotherapy 6%
41. High-Throughput Nucleotide Sequencing 6%
42. Chromatin Assembly and Disassembly 6%
43. Formaldehyde 6%
44. Paraffin 6%
45. GSK2879552 6%
46. Progression-Free Survival 6%
47. Gene Fusion 6%
48. Diffusion Magnetic Resonance Imaging 6%
49. Immunotherapy 5%
50. Alkylating Agents 5%